Other genes, such as PREPL (prolyl endopeptidase-like—usually involved in neurological and metabolic pathways) and MTURN (a neural progenitor differentiation regulator associated with cancer progression), emerged as potential biomarkers influencing survival outcomes. This evidence concerns the gene MTURN and cancer.